Time to act on trials
Many of the worst economic and bureaucratic burdens that have proved such a deterrent to multi-country clinical trials look set to be addressed with the overhaul of the EU Clinical Trials Directive, but should we [more]
Editorial
Penalised for having cancer
Many cancer patients are being tipped into poverty as a direct result of their illness, which adds stress and misery to an already very difficult situation. In this editorial, Cancer World looks at the many [more]
Personalised medicine: a note of caution
Tailoring a patient’s treatment to the particular biology of their cancer holds out the enticing prospect of avoiding over-treatment and reducing unnecessary toxicity. But delivering the right option for the right patient at the right [more]
Winning or losing? ESO asks the experts
To mark 30 years of helping to improve the quality of care provided to cancer patients, ESO is convening a jury of 100 experts at the World Oncology Forum in Lugano this October to examine [more]
Framing the argument over futile care
This editorial argues that handling the transition from active to palliative care is indeed a weak point in oncology, and if the cancer community fails to address it, we will leave it open to the [more]
Join the battle for biomedical research
Once every seven years an opportunity arises to influence the shape of the European science research effort. This editorial takes a look at what is at stake in the current discussions around the European Research [more]
Aspirin for cancer prevention: why wait?
The prospect is too exciting to dismiss: a single, inexpensive pill that, taken regularly, can reduce the risk of developing or dying from several types of cancer. The prospect is too exciting to dismiss: a [more]
To cut or not to cut? Why surgeons don’t have all the answers
Years ago, surgery was the principal way of treating most cancers. Nowadays, surgery has become more conservative as the concept of operability is changing. Download full article
Securing quality cancer care: Governments must step up to the plat
The OECD recently made a cross-country analysis of how cancer care systems work in an attempt to explain variations in cancer survival in Europe.
Patients need information. Is that clear?
The urgent quest for novel cancer treatments engages much of our attention, but could we be overlooking other opportunities for increasing patients’ survival and quality of life? Download full article
Adapting services to the age of oral therapies
The increasing use of oral cancer drugs is contributing to a change in the way cancer services are organised, leading to many more patients receiving care in an ambulatory setting. Download full article
A million voices against cancer
The UN General Assembly Special Session on Non-Communicable Diseases this September offers an all-too-rare window of opportunity to push cancer well up the global health agenda. Read more to see how you can help! Download [more]
Our role in moulding the image of cancer
The mass media and high-profile cancer campaigns have a major influence in shaping public perceptions of cancer. But who can influence the media? Download full article